IP Library Granted Patent US 9,527,074
Granted Patent B2
US 9,527,074 · App. 15/216,128 · Granted Dec 27, 2016

Processing containers

Inventors: Simon Jonathon Spence (Hawthorn, AU); Richard Alexander Grant (St. Kilda West, AU); Timothy Doyle Peele (Raleigh, NC); William Samuel Hunter (Jan Juc, AU); Ashraf F. Abdelmoteleb (Ferntree Gully, AU); David Thomas Kneen (Richmond, AU); Robert Alister Neil (Richmond, AU); Simon Harris (Keysborough, AU)
Assignee: Argos Therapeutics, Inc.
B01L1/00G01L1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,527,074
App. No.
15/216,128
Granted
Dec 27, 2016
Kind
B2
Abstract

Processing containers include a first member having a substantially rigid body with a plurality of regions defining spaced apart workstations and a flexible barrier member sealably attached to the first member to define a closed chamber over the plurality of workstations. The flexible barrier is substantially impermeable and includes or is a manipulation tool that is sealably attached to the barrier. The manipulation tool has a first internal interface that resides in the closed chamber under the flexible barrier and a second external interface that resides outside the closed chamber. The processing containers are particularly suitable for automated processing of nucleic acids and other samples. The manipulation tool can cooperate with or include a pipette head. When the barrier is sealed, the barrier separates the contents of the container from a robotic arm or other manipulation device.

Claims (22)

1. A processing container, comprising:

a first member having a substantially rigid body with a plurality of regions defining spaced apart workstations; and

a flexible barrier member sealably attached to the first member to define a closed chamber over the plurality of workstations, wherein the flexible barrier member is substantially impermeable, and wherein the flexible barrier member comprises a manipulation tool that is integrated therein and/or sealably attached thereto, the manipulation tool having a first internal interface that resides in the closed chamber under the flexible barrier member and a second external interface that resides outside the closed chamber.

2. The container of claim 1 , wherein the flexible barrier member and first member are single-use disposable.

3. The container of claim 1 , wherein the first member has a wall segment configured to snugly receive an external cooling element, wherein, in operation, the wall segment cooperates with the cooling element to define a condensation wall inside the container.

4. The container of claim 1 , wherein the first member comprises a sidewall with a side entry receiving aperture, and wherein the side entry receiving aperture is sealably covered by a substantially laterally extending sleeve that is configured to allow at least one item to enter into and exit from an interior region of the container.

5. The apparatus of claim 4 , further comprising a manifold configured to hold at least one nucleic acid binding column, the manifold configured to releasably engage the second interface of the tool to automatically move between at least two of said plurality of stations.

6. The apparatus of claim 5 , wherein the manifold comprises a handle, and wherein the second interface is configured to engage the handle to move the manifold to and from at least two stations.

7. The container of claim 1 , wherein one of the workstation regions is configured to hold a PCR plate, another of the workstation regions is configured to hold a pipette rack with pipette tips, and another of the workstation regions is configured to hold a tray of sealed reagent vessels.

8. The container of claim 1 , wherein the tool first internal interface comprises a pipette tip adapter for releasably engaging pipette tips stored within the container.

9. The container of claim 1 , wherein the flexible barrier member has a center portion that merges into an outer perimeter portion, and wherein the center portion of the flexible barrier member can move relative to the outer perimeter portion, and wherein the flexible barrier member has sufficient flexibility so that the center portion is able to translate in three dimensions and change in shape while the outer perimeter portion remains sealably attached to the container.

10. The container of claim 1 , wherein the first internal interface of the manipulation tool travels between about 4-24 inches in a vertical direction and about a length and width of the container in the sealed chamber.

11. The container of claim 1 , further comprising nucleic acid samples in the sealed chamber, wherein the manipulation tool is attached to a center portion of the flexible barrier member, and wherein the workstations are configured to process the nucleic acid samples.

12. A processing container, comprising:

a first member having a substantially rigid body with a plurality of regions defining spaced apart workstations; and

a flexible barrier member sealably attached to the first member to define an internal chamber enclosing the plurality of workstations, wherein the flexible barrier member is substantially impermeable, and wherein the flexible barrier member cooperates with a manipulation tool that can move the flexible barrier while maintaining a sealed state of the internal chamber.

13. The container of claim 12 , wherein the flexible barrier member and first member are single-use disposable.

14. The container of claim 12 , further comprising nucleic acid samples in the internal chamber, and wherein the workstations are configured to process the nucleic acid samples.

15. The container of claim 12 , further comprising a plurality of flexible tubes extending out of the first member.

16. The container of claim 12 , wherein the internal chamber comprises a patient sample comprising nucleic acid and magnetic beads for purifying the sample.

17. The container of claim 12 , further comprising outlet tubing sealably attached to the first member that merges into aliquot containers outside of the internal chamber of the container.

18. The container of claim 12 , further comprising a circulating closed air system with intake and outlet tubing connected to the isolation container.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: ARGOS THERAPEUTICS, INC.
To: COIMMUNE, INC.
Reel/Frame 048645/0673 →
CHANGE OF NAME Recorded Sep 18, 2016
From: KIRIN BEER KK
To: KIRIN PHARMA KK
Reel/Frame 040069/0085 →
MERGER Recorded Sep 18, 2016
From: KIRIN PHARMA KK
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 040069/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2016
From: PEELE, TIMOTHY DOYLE
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KK
Reel/Frame 039774/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2016
From: SPENCE, SIMON JONATHON; GRANT, RICHARD ALEXANDER; HUNTER, WILLIAM SAMUEL; ABDELMOTELEB, ASHRAF F.; KNEEN, DAVID THOMAS; NEIL, ROBERT ALISTER; HARRIS, SIMON
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KK
Reel/Frame 039774/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2016
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 039774/0447 →
Continuity (7)
Division 14692131 · Apr 21, 2015
Continuation 13845725 · Mar 18, 2013
Continuation 13490863 · Jun 7, 2012
Division 13235922 · Sep 19, 2011
Division 12159748
Provisional Application 60760087 · Jan 18, 2006
Related Publication 20160326573A1 · Nov 10, 2016